AFT Pharmaceuticals Limited

NZSE AFT.NZ

AFT Pharmaceuticals Limited Operating Income for the year ending March 31, 2024: USD 14.49 M

AFT Pharmaceuticals Limited Operating Income is USD 14.49 M for the year ending March 31, 2024, a 24.09% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.
  • AFT Pharmaceuticals Limited Operating Income for the year ending March 31, 2023 was USD 11.67 M, a -16.10% change year over year.
  • AFT Pharmaceuticals Limited Operating Income for the year ending March 31, 2022 was USD 13.92 M, a 75.90% change year over year.
  • AFT Pharmaceuticals Limited Operating Income for the year ending March 31, 2021 was USD 7.91 M, a -36.58% change year over year.
  • AFT Pharmaceuticals Limited Operating Income for the year ending March 31, 2020 was USD 12.48 M, a 197.69% change year over year.
Key data
Date Operating Income EBIT EBITDA Net Income
Market news
NZSE: AFT.NZ

AFT Pharmaceuticals Limited

CEO Dr. Hartley Atkinson Ph.D.
IPO Date Dec. 21, 2015
Location New Zealand
Headquarters 129 Hurstmere Road
Employees 110
Sector Health Care
Industries
Pharmaceuticals
Description

AFT Pharmaceuticals Limited, together with its subsidiaries, engages in the development and sale of pharmaceutical products in New Zealand, Australia, Asia, and internationally. It offers products for use in the areas of allergy, cold and flu, digestive health, eye care, first aid, nail care, oral care, pain management, skin care, and supplements, as well as other products. AFT Pharmaceuticals Limited was incorporated in 1997 and is headquartered in Auckland, New Zealand.

StockViz Staff

January 15, 2025

Any question? Send us an email